New Markers of Inflammation and Endothelial Cell Activation
Top Cited Papers
- 21 October 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (16) , 1917-1923
- https://doi.org/10.1161/01.cir.0000089190.95415.9f
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic PatientsCirculation, 2003
- Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectorisThe American Journal of Cardiology, 2003
- Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular CellsCirculation, 2002
- Inflammation in atherosclerosisNature, 2002
- Endothelial functionThe American Journal of Cardiology, 2002
- Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1Journal of Biological Chemistry, 2002
- A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NFκB and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction PathwaysJournal of Biological Chemistry, 2001
- CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle CellsThe American Journal of Pathology, 2000
- Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cellsEuropean Journal of Immunology, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994